Centogene NV Net Income
| CNTGF Stock | 0.11 0.00 0.00% |
As of the 17th of February 2026, Centogene shows the Mean Deviation of 0.8381, risk adjusted performance of 0.0634, and Standard Deviation of 2.49. Centogene NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Centogene NV variance and skewness to decide if Centogene NV is priced correctly, providing market reflects its regular price of 0.11 per share. As Centogene NV appears to be a penny stock we also recommend to validate its information ratio numbers.
Centogene Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 3 M | Enterprise Value Revenue 1.3326 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -40.9 M | -42.9 M | |
| Net Loss | -32 M | -33.6 M |
Centogene | Net Income | Build AI portfolio with Centogene Stock |
The Net Income trend for Centogene NV offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Centogene is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Centogene's Net Income Growth Pattern
Below is the plot of the Net Income of Centogene NV over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Centogene NV financial statement analysis. It represents the amount of money remaining after all of Centogene NV operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Centogene's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Centogene's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (35.53 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Centogene Net Income Regression Statistics
| Arithmetic Mean | (26,856,091) | |
| Coefficient Of Variation | (27.67) | |
| Mean Deviation | 6,302,470 | |
| Median | (21,986,000) | |
| Standard Deviation | 7,431,685 | |
| Sample Variance | 55.2T | |
| Range | 24.3M | |
| R-Value | (0.71) | |
| Mean Square Error | 29.6T | |
| R-Squared | 0.50 | |
| Significance | 0 | |
| Slope | (1,038,945) | |
| Total Sum of Squares | 883.7T |
Centogene Net Income History
Other Fundumenentals of Centogene NV
Centogene Net Income component correlations
Click cells to compare fundamentals
Can Life Sciences Tools & Services industry sustain growth momentum? Does Centogene have expansion opportunities? Factors like these will boost the valuation of Centogene. Projected growth potential of Centogene fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Centogene demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.47) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) |
Investors evaluate Centogene NV using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Centogene's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Centogene's market price to deviate significantly from intrinsic value.
It's important to distinguish between Centogene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Centogene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Centogene's market price signifies the transaction level at which participants voluntarily complete trades.
Centogene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Centogene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Centogene.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Centogene on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Centogene NV or generate 0.0% return on investment in Centogene over 90 days. Centogene is related to or competes with Mettler Toledo, Alcon AG, ResMed, Haleon Plc, Cardinal Health, Becton Dickinson, and Insmed. Centogene is entity of United States. It is traded as Stock on NASDAQ exchange. More
Centogene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Centogene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Centogene NV upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.042 | |||
| Maximum Drawdown | 18.33 |
Centogene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Centogene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Centogene's standard deviation. In reality, there are many statistical measures that can use Centogene historical prices to predict the future Centogene's volatility.| Risk Adjusted Performance | 0.0634 | |||
| Jensen Alpha | 0.1512 | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | 0.7435 |
Centogene February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0634 | |||
| Market Risk Adjusted Performance | 0.7535 | |||
| Mean Deviation | 0.8381 | |||
| Coefficient Of Variation | 1425.68 | |||
| Standard Deviation | 2.49 | |||
| Variance | 6.19 | |||
| Information Ratio | 0.042 | |||
| Jensen Alpha | 0.1512 | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | 0.7435 | |||
| Maximum Drawdown | 18.33 | |||
| Skewness | 1.17 | |||
| Kurtosis | 11.15 |
Centogene NV Backtested Returns
At this point, Centogene is out of control. Centogene NV secures Sharpe Ratio (or Efficiency) of 0.0735, which signifies that the company had a 0.0735 % return per unit of risk over the last 3 months. We have found sixteen technical indicators for Centogene NV, which you can use to evaluate the volatility of the firm. Please confirm Centogene's Mean Deviation of 0.8381, risk adjusted performance of 0.0634, and Standard Deviation of 2.49 to double-check if the risk estimate we provide is consistent with the expected return of 0.19%. Centogene has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Centogene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Centogene is expected to be smaller as well. Centogene NV right now shows a risk of 2.61%. Please confirm Centogene NV variance, skewness, as well as the relationship between the Skewness and day typical price , to decide if Centogene NV will be following its price patterns.
Auto-correlation | -0.44 |
Modest reverse predictability
Centogene NV has modest reverse predictability. Overlapping area represents the amount of predictability between Centogene time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Centogene NV price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Centogene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.44 | |
| Spearman Rank Test | 0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Centogene Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Centogene NV reported net income of (35.53 Million). This is much lower than that of the Life Sciences Tools & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Centogene Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Centogene's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Centogene could also be used in its relative valuation, which is a method of valuing Centogene by comparing valuation metrics of similar companies.Centogene is currently under evaluation in net income category among its peers.
Centogene Fundamentals
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (0.63) % | ||||
| Current Valuation | 76.09 M | ||||
| Shares Outstanding | 27 M | ||||
| Shares Owned By Institutions | 1.45 % | ||||
| Number Of Shares Shorted | 81.71 K | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 0.06 X | ||||
| Revenue | 48.54 M | ||||
| Gross Profit | 17.7 M | ||||
| EBITDA | (32.89 M) | ||||
| Net Income | (35.53 M) | ||||
| Total Debt | 25.88 M | ||||
| Book Value Per Share | (0.87) X | ||||
| Cash Flow From Operations | (31.75 M) | ||||
| Short Ratio | 0.82 X | ||||
| Earnings Per Share | (1.47) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 384 | ||||
| Beta | 0.1 | ||||
| Market Capitalization | 2.96 M | ||||
| Total Asset | 77.16 M | ||||
| Retained Earnings | (177.07 M) | ||||
| Working Capital | 653 K | ||||
| Net Asset | 77.16 M |
About Centogene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Centogene NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centogene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centogene NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Can Life Sciences Tools & Services industry sustain growth momentum? Does Centogene have expansion opportunities? Factors like these will boost the valuation of Centogene. Projected growth potential of Centogene fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Centogene demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.47) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) |
Investors evaluate Centogene NV using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Centogene's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Centogene's market price to deviate significantly from intrinsic value.
It's important to distinguish between Centogene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Centogene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Centogene's market price signifies the transaction level at which participants voluntarily complete trades.